Proteomics in Rheumatoid Arthritis Research

Area of Science:

• Biochemistry
• Immunology
• Medical Diagnostics

Background:

• Rheumatoid arthritis (RA) is a prevalent chronic inflammatory autoimmune disease.
• Current RA diagnosis relies on clinical symptoms, lacking objective assessment tools for disease activity and severity.
• There is a critical need for novel biomarkers to guide RA management.

Purpose of the Study:

• To review the application of proteomics in rheumatoid arthritis research.
• To highlight the potential of proteomics in identifying novel biomarkers for RA.
• To discuss proteomics as a tool for discovering new treatment targets in RA.

Main Methods:

• Systematic review of proteomic studies in rheumatoid arthritis.
• Analysis of proteomic data from various biological samples including synovial fluid, tissue, blood, and urine.
• Examination of proteomic techniques applied to RA patients and animal models over the last decade.

Main Results:

• Proteomics has emerged as a key technology for large-scale protein identification and characterization in RA.
• Proteomic approaches have been applied across diverse sample types in RA research.
• This field holds significant promise for biomarker discovery and therapeutic target identification.

Conclusions:

• Proteomics is instrumental in advancing the understanding and diagnosis of rheumatoid arthritis.
• The identification of protein biomarkers through proteomics can significantly improve disease activity assessment and treatment monitoring.
• Proteomic insights are crucial for developing more effective therapeutic strategies for RA.